Genome Web Breaking News
- CareDx Preliminary Q1 Revenues Up 47 Percent; Withdraws FY2020 Guidance
- Tens of Thousands of Protein-Protein Interactions Reported in Human Reference Interactome Map
- 23andMe to Study Genetic Factors of COVID-19 Severity Using Data From Consented Customers
- Pacific Biosciences Shares Spike on SARS-CoV-2 Research Initiatives
- BillionToOne Developing Coronavirus Dx Test Based on Sanger Sequencing
Stat
- Trump faulted the WHO’s coronavirus response. But it’s guided by rules the U.S. helped write
- STAT Plus: Opioid-overdose prescriptions may go unfilled due to the cost
- With the pandemic sidelining routine care, a trade group urges the government to pay for digital therapeutics
- ‘Smart toilet’ could monitor for signs of illness in urine and stool, study finds
- Opinion: CDC: remember who you are
NYT science news
- Australia Investigates Why a Cruise Ship Allowed Infected Passengers to Disembark: Live Coverage
- Most New York Coronavirus Cases Came From Europe, Genomes Show
- C.D.C. Releases Early Demographic Snapshot of Worst Coronavirus Cases
- Poachers Kill More Rhinos as Coronavirus Halts Tourism to Africa
- Hydroxychloroquine and Coronavirus: Fact-Check on the Malaria Drug Trump Keeps Pushing
Xconomy news
- Investors Bet on Next-Gen Telehealth as COVID-19 Fuels Adoption
- Gilead Heightens Inflammatory Disease Focus With Second Genome Microbiome Deal
- Organovo Future Unclear After Shareholders Reject Tarveda Merger
- Roche Pays $190M to Start RNA Drug Alliance With Arrakis Therapeutics
- Keros Therapeutics Raises $96M in Upsized IPO to Fuel Clinical Tests
Fierce Biotech
- Xerox set to mass produce Vortran’s disposable emergency ventilators
- GSK, AstraZeneca to launch COVID-19 testing lab at University of Cambridge
- AstraZeneca targets summer start for COVID-19 antibody trial
- Worldwide clinical trials take a major hit from pandemic, with endocrine targeted tests worst hit
- Tackling COVID-19 with the help of the virus that causes kennel cough in dogs
Fierce Medical Devices
- Xerox set to mass produce Vortran’s disposable emergency ventilators
- GSK, AstraZeneca to launch COVID-19 testing lab at University of Cambridge
- Current COVID-19 antibody tests aren't accurate enough for mass screening, say Oxford researchers
- U.S. government funds OraSure's at-home spit test for coronavirus infections
- Gilead taps Second Genome for microbiome biomarker help in a potential $1.5B deal